Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Many young women have Polycystic Ovarian Syndrome (PCOS), which is often linked with irregular periods, depression, low self-esteem, and insomnia. Lifestyle and diet changes, along with regular counseling, can help manage these symptoms.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Adrenal disorders can cause lasting brain and behavior issues in children.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

The flap advancement technique effectively treats severe scalp skin conditions, preserving hair and improving appearance.

Hair loss significantly affects quality of life, wet combing is better than visual inspection for finding head lice, many with oral lichen planus have allergies, and wet wraps with steroids quickly improve itchy skin conditions.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.